Contrast Media & Molecular Imaging

Contrast Media & Molecular Imaging / 2019 / Article
Special Issue

Imaging Biomarkers in Translational Small Animal Models

View this Special Issue

Review Article | Open Access

Volume 2019 |Article ID 3128529 |

Richa Gandhi, Charalampos Tsoumpas, "Preclinical Imaging Biomarkers for Postischaemic Neurovascular Remodelling", Contrast Media & Molecular Imaging, vol. 2019, Article ID 3128529, 21 pages, 2019.

Preclinical Imaging Biomarkers for Postischaemic Neurovascular Remodelling

Academic Editor: Barbara Palumbo
Received22 Aug 2018
Revised22 Nov 2018
Accepted04 Dec 2018
Published03 Feb 2019


In the pursuit of understanding the pathological alterations that underlie ischaemic injuries, such as vascular remodelling and reorganisation, there is a need for recognising the capabilities and limitations of in vivo imaging techniques. Thus, this review presents contemporary published research of imaging modalities that have been implemented to study postischaemic neurovascular changes in small animals. A comparison of the technical aspects of the various imaging tools is included to set the framework for identifying the most appropriate methods to observe postischaemic neurovascular remodelling. A systematic search of the PubMed® and Elsevier’s Scopus databases identified studies that were conducted between 2008 and 2018 to explore postischaemic neurovascular remodelling in small animal models. Thirty-five relevant in vivo imaging studies are included, of which most made use of magnetic resonance imaging or positron emission tomography, whilst various optical modalities were also utilised. Notably, there is an increasing trend of using multimodal imaging to exploit the most beneficial properties of each imaging technique to elucidate different aspects of neurovascular remodelling. Nevertheless, there is still scope for further utilising noninvasive imaging tools such as contrast agents or radiotracers, which will have the ability to monitor neurovascular changes particularly during restorative therapy. This will facilitate more successful utility of the clinical imaging techniques in the interpretation of neurovascular reorganisation over time.

1. Introduction

Oxygen is essential for the survival and basic functioning of biological systems. A stable equilibrium between the supply and usage of oxygen in biological systems generates oxygen gradients, wherein areas with low concentrations of oxygen (i.e., hypoxic regions) are situated relatively distant from the central vasculature. These oxygen gradients contribute to a healthy and functioning physiology, and their disturbance—for example, due to injury or disease—can confer debilitating effects on the functioning physiology [1]. Neural ischaemia is typically a hypoxic phenomenon, usually the result of some kind of traumatic injury or vascular disruption, developing from a deficiency in blood flow to brain tissue. This interrupted circulatory flow then triggers changes in the brain’s metabolic processes [2]. Immediately following ischaemic injury, a series of biochemical reactions ensue within the brain, which are collectively termed the ischaemic cascade. The ischaemic cascade involves biochemical energy depletion and the inability to maintain ionic gradients across cell membranes due to the restriction in blood supply. This eventually triggers cytotoxic and vasogenic oedema, as well as apoptotic and necrotic processes, which ultimately result in the deterioration of healthy brain tissue [35]. This cascade is elicited in patients who experience ischaemic stroke (Figure 1) [6].

One of the outcomes of an ischaemic stroke is the structural alteration of blood vessels to accommodate for the changes in haemodynamic conditions. This remodelling of the vasculature involves alterations in angiogenesis, the development of new blood vessels from preexisting ones; angionecrosis, the death of blood vessels or of the walls of blood vessels; migration of cells that compose blood vessels; and production and/or degradation of the extracellular matrix. Essentially, vascular remodelling is dependent on an interplay of haemodynamic stimuli, growth factors, and vasoactive substances [7]. As a result of the inclusion of a wide range of processes, it is essential to briefly address that the terminology of vascular “remodelling” may be used interchangeably with “alterations,” “plasticity,” “reorganisation,” “rearrangement,” or other similar keywords in the literature. The biological process involving this interplay is described in Figure 2, wherein the detection and relay of haemodynamic signals ultimately lead to vascular reorganisation.

Knowledge of the overall neurovasculature is useful for distinguishing the blood vessel or group of vessels that may be associated with an ischaemic stroke; unusual vascular patterns can then be attributed to other diseases, such as seizures, intracerebral haemorrhage, or brain tumours [8]. The functional deficits resulting from an ischaemic stroke are dependent on the cerebral arteries—and thus the brain regions—that are disrupted [6]. The cerebral hemispheres are each supplied by the posterior, middle, and anterior cerebral arteries. The posterior cerebral arteries originate from the basilar artery and supply the medial and posterior regions of the temporal and occipital lobes, as well as the thalamus and brainstem regions. The middle cerebral arteries, which originate from the supraclinoid internal carotid, supply the anterior and lateral regions of the temporal lobes and lateral regions of the parietal and frontal lobes. The anterior cerebral arteries also originate from the supraclinoid internal carotid and supply the anterior regions of the basal ganglia, as well as the medial regions of the parietal and frontal lobes [9].

Imaging techniques play a significant role in clinical research; they are crucial for enhanced visualisation to better understand biological processes. The world’s first images of human brain metabolism were acquired via continuous inhalation of positron-emitting radioactive oxygen ([15O]) to study the neurovascular distribution and accumulation of oxygen [10, 11]. Since then, our understanding of neurovascular dynamics has significantly progressed; various neuroimaging techniques with additional advantages, such as improved spatial resolution and the capacity for longitudinal imaging, are implemented in preclinical research and clinical practice. Neuroimaging (i.e., the use of imaging for neurological structures) can serve two purposes: (1) to differentiate amongst various morphological structures and (2) to visualise functional changes in neural plasticity following injury [6]. One such example involves imaging patients immediately after the onset of a stroke and posttraumatically at regular intervals. It is well established that patients who experience ischaemic stroke subsequently undergo vascular remodelling within the brain [2, 5, 7]. Studies of stroke in humans are limited because of the difficulties in collecting postmortem tissue samples when neuronal death occurs. Thus, neural ischaemia research is largely built upon information gathered from studies of animal models. When ischaemia is induced in experimental rodent models, for example, blood flow is disrupted to restrict the delivery of oxygen and glucose to neurons, eventually causing a depletion in biochemical energy [1, 12].

The aim of this review is to provide a guide to current imaging techniques being used to explore neurovascular remodelling in a preclinical in vivo setting. This review will contribute to the following:(i)Identify and distinguish preclinical imaging options used in the last 10 years(ii)Compare these techniques across common parameters(iii)Explore the potential applications of novel advances in imaging technologies(iv)Discuss how these imaging techniques could be translated to improve the medical management of ischaemic stroke

2. Materials and Methods

2.1. Search Strategy

The PubMed® and Elsevier’s Scopus online databases were used to retrieve journal papers. Titles, keywords, and abstracts were scanned for the search terminology using the search engines. The citations and references of any retrieved papers were also scanned for any relevant literature that may have been missed in the initial search. Boolean operating search strings were employed to ensure that the most suitable papers were retrieved. Table 1 outlines the search strategy that was implemented for literature retrieval.

Initial search terminologySynonyms and related terminologyTruncations and wildcards

low blood
low blood flow
low oxygen


blood vessels



The initial search terminology stemmed from the wording of the overall aim of the review. The inclusion of alternative terminology and truncation and wildcard operators helped to uncover a wider range of papers from the databases. Some searches were also conducted with the exclusion of “remodelling” to assess whether imaging methods could potentially be implemented for this purpose.
2.2. Eligibility Criteria

Applying inclusion and exclusion parameters to the literature search process facilitated the retrieval of the most appropriate papers. Search results were restricted to papers published in English within the last 10 years (i.e., between 2008 and 2018, inclusive), as the translation of papers published in non-English languages may have distorted the understanding of the research. In vivo studies of small animals were included, and several papers discussing the same imaging technology were not disregarded, as these would only strengthen any common conclusions formed from these studies. Only primary research papers were included in the final analysis; other secondary or tertiary publications such as reviews, books, conference proceedings, presentations, and abstracts were only referred to for background or follow-up information and are cited accordingly in the discussion.

2.3. Quality Appraisal

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed to ensure that the most appropriate research papers were included in this review. The PRISMA guidelines were established by David Moher and colleagues to conceptually represent the progressions within the field of systematic literature reviews. The papers that were retrieved from the search process following this model were systematically categorised according to their significance in helping to answer the overall aim of this research [13].

2.4. Data Collection and Analysis

Each of the retrieved papers from the literature search focussed on one or more imaging techniques. The next step involved assessing these imaging techniques based on relevant parameters to evaluate whether they could be implemented to observe neurovascular remodelling following ischaemic injury. Accordingly, the following details were extracted from each of the retrieved papers, where available: imaging technique, purpose of the study, animal model used, spatial resolution or field of view, duration of scanning, contrast agent or molecular probe utilised, safety considerations for implementation in humans, and considerations for modality-specific image interpretation.

Although an effective imaging technique may offer excellent image resolution with minimal patient invasiveness, it may not be considered optimal for the purposes of clinical translation if the acquired data are exceedingly difficult and time-consuming to acquire and even process. By analysing and discussing comparisons between different technical characteristics and across a variety of imaging techniques, appropriate strategies to employ for postischaemic imaging can then be determined.

3. Results

The PRISMA model, as outlined in the previous section, was used to select the literature for this review. The articles’ filtering process is presented in Figure 3.

The results of the literature search essentially revealed a number of imaging parameters for each imaging technique that may be relevant for the imaging of neural vasculature, particularly following ischaemic trauma. These relevant parameters, along with a brief overview of the imaging techniques, are presented in Table 2.

ReferenceMethod and application (models)Imaging parametersContrast agent or molecular probeSafety considerations for clinical translationApplications

Bosomtwi et al. [14]MRI to observe poststroke vascular changes (rats)FOV: 32 mmFeridexNoninvasiveTissues can be monitored long term through stages of angiogenesis enabling evaluation of vascular remodelling

Bosomtwi et al. [15]MRI in combination with LSCM to visualise postischaemic changes in vasculature (rats)FOV: 32 mmMIONsNoninvasive; high doses of intravascular agent are requiredLSCM can be used to validate MRI data; poststroke vascular remodelling can be three-dimensionally quantified

Brunner et al. [16]fUS to measure postischaemic cerebral blood volume (rats)Resolution: 100 μm, FOV: 12.8 × 9 mm2, duration: approx. 3 minNoneNo contrast agent injections are requiredStroke longitudinally studied across all stages; can image whilst in motion, as the probe is implanted on the head

Cai et al. [17]PET to observe VEGFR expression in poststroke angiogenesis (rats)64Cu-DOTA-VEGF121Some cellular VEGFRs may be visualised, resulting in the potential to observe poststroke reorganisation and plasticity

Deddens et al. [18]MRI to detect vascular remodelling after cerebral ischaemia (mice)FOV: 1 × 1.2 × 2 cm3PECAM-1-targetted FeOx microparticlesPECAM-1 can be used to assess poststroke vascular remodelling

Ding et al. [19]MRI to visualise poststroke cerebral angiogenesis (rats)FOV: 32 × 32 × 16 mm3Gd-DTPANoninvasiveDetect angiogenesis and determine the temporal profile of angiogenic processes

Errico et al. [20]Ultrafast US localisation microscopy to visualise neurovasculature and quantify haemodynamic characteristics (rats)Resolution: 12.5 × 2.5 × 1 μm3Inert perfluorocarbon-filled microbubblesMicrobubbles are clinically approved contrast agentsEven slight haemodynamic changes in neurovasculature can be monitored; the resolution can be enhanced by localising microbubbles directly from radiofrequency data; motion correction algorithms needed

Figueiredo et al. [21]CTATo observe cerebral vascular anatomy and blood flow (mice)Resolution: 163μm3, duration: 20–40 sIomeprolInjection of contrast agent is requiredCan detect changes in the diameter of vasculature
MRAResolution: 31 × 31 × 93 μm3, FOV: 12 × 16 mm2, duration: 58 minNoneNo ionising radiation
Digital subtraction angiographyResolution: 14 × 14 μm2, duration: 3 sIomeprolLow injection volume and dose of radiation, although much more invasive than CTA and MRACan detect changes in intracerebral blood flow

Gramer et al. [22]PET, LSI, and RGB reflectometry to measure CBF, blood oxygenation, and glucose metabolism (rats)Resolution (PET): 1.3 mm (FWHM), FOV: 12 × 7 mm2[18F]FDGThin-skull preparation is requiredCan be used to quantify metabolic activity of neurovasculature in real time making it suitable for studying pathological conditions. Partial volume is an issue

Horton et al. [23]Triphoton fluorescence microscopy to visualise hippocampal vasculature (mice)Resolution: 4.4 μm (axial, FWHM)Dextran-coupled Texas Red dyeOvercomes the limitations of two-photon microscopy, such as signal-to-background ratio of excitation in scattering tissues and lack of fluorescent labels that can be used

Howles et al. [24]Contrast-enhanced MRA to visualise neurovasculature (mice)Resolution: 52 × 52 × 100 μm3, FOV: 20 × 20 × 8 mm3, duration: approx. 12 minSC-Gd liposomal nanoparticlesSC-Gd allows for high contrast-to-noise ratio; useful to visualise very small vascular structures

Hu et al. [25]Optical-resolution PAM to study micro-haemodynamic activities (rodents)Resolution: 5 × 15 μm2NoninvasiveCan help quantify changes in metabolic parameters

Huang et al. [26]MRI to assess vascular reactivity and functionality during postischaemic proangiogenic vascular remodelling (rats)FOV: 2.56 × 2.56 cm2Anaesthesia protocols must be optimised to minimise physiological disturbance

Jimenez-Xarrie et al. [27]MRI to assess postischaemic cerebrovascular damageFOV: 32 × 32 mm, duration: 9 min 17 sNoneIsoflurane anaesthesia can affect stroke outcomes and evaluation of vascular changesLong-term vascular consequences of ischaemia with coincident hypertension can be studied

Kolodziej et al. [28]SPECT to study CBF (mice)Resolution: 0.7 mm (FWHM), FOV: 20.9 mm (axial), duration: approx. 2 h99mTc-HMPAO99mTc-HMPAO is lipophilic and is quickly cleared from the plasmaUses pinhole imaging for higher resolution

Lake et al. [29]MRI to assess poststroke brain morphology and vascular function (rats)Resolution: 0.1 × 0.1 mm2, duration: <12 minPropofol anaesthesia induces 20–60% regional vasoconstriction, which may influence vascular studiesFunctional MRI can be used to measure resting blood flow and cerebrovascular reactivity; structural MRI may have limited sensitivity to detect subtle changes in tissue morphology

Lecoq et al. [30]Two-photon phosphorescence lifetime microscopy to measure the partial pressure of oxygen and blood flow (mice)Resolution: <1 μm (lateral)Phosphorescent nanoprobe PtP-C343Minimally invasive; the probe is neither toxic nor phototoxicOxygen gradients in microvascular networks can be distinguished; this is particularly useful for postischaemia imaging

Letourneur et al. [31]Two-photon laser scanning microscopy to longitudinally image vascular development (mice)Duration: 50–150 sFluorescein-conjugated dextran and Texas Red-dextranRequires thinning of the skull; head must be immobilisedCan longitudinally image the same areas over many days; can measure flow dynamics over time in relation to changes in vessel diameter

Li et al. [32]LSI to study neurovasculature (rats)Resolution: 6.7 × 6.7 μm2NoneRequires thinning of the skullDifferent circulatory dynamics can be observed at different spatial locations

Liao et al. [33]Functional PAM to study functional changes in total haemoglobin concentration, cerebral blood volume, and haemoglobin O2 saturation in cerebral blood vessels (rats)Resolution: 36 × 65 μm2NoneCan be complemented with other imaging modalities for label-free visualisation of neurovasculature

Lin et al. [34]3D ΔR2-based microscopy of MRA to visualise poststroke changes in neurovasculature (rats)Resolution: 54 × 54 × 72 μm3, FOV: 2.8 × 2.8 × 1.4 cm3, duration: 76 minMIONsGreater magnetic fields may be needed to visualise smaller vesselsCan simultaneously visualise microvascular morphology and reveal physiological properties of microvascular cerebral blood volume

Luckl et al. [35]LSI and imaging of intrinsic signals to study CBF dynamics during ischaemia (rats)Resolution: 140 μm every 2 s, FOV: 5 × 5 mm2Erythrosin B dyeRequires thinning of the skull for better observationVascular changes in metabolism can be quantified

Miao et al. [36]LSI to study angiogenesis (rats)FOV: 4.7 × 4.7 mm2NoneRequires thinning of the skullCBF under various pathological states can be analysed, and smaller vessels can be enhanced; results can be affected by motion artefacts

Nagaraja et al. [37]MRI to visualise poststroke changes in the BBB (rats)FOV: 32 mmGd-DTPA and Gd-DTPA linked to bovine serum albumin and Evans blue dyeNoninvasiveDifferent measurements are obtained with different contrast agents; quantifying BBB permeability can help in understanding the progression of ischaemic injury

Sakadžić et al. [38]Two-photon phosphorescence lifetime microscopy to measure partial pressure of oxygen in cortical microvasculature under hypoxic conditions (rats, mice)Phosphorescent nanoprobe PtP-C343Minimally invasive with low doses of the probe required; no detected leakage of the probe into interstitial spacesThe partial pressure of oxygen can be simultaneously assessed at various positions and depths, making it more feasible to functionally study transient changes in oxygen levels

Schambach et al. [39]Volume-CTA to visualise cerebral vessels (mice)Duration: 40 sIodinated contrast agentLarge dose of contrast agent is requiredChanges in vessel diameter can be monitored

Schroeter et al. [40]PETTo observe postischaemic vascular changes (rats)Duration: up to 60 min[18F]FDG and [11C]PK11195NoninvasiveCharacterise neuroinflammation and metabolic disruptions repeatedly over time.
MRIFOV: 3.0 cmNoninvasiveCan help localise areas of infarction

Seo et al. [41]Contrast-enhanced μCT to visualise poststroke changes in cerebral vasculature (rats)Duration: approx. 2 minIopromideHigh doses of iodinated contrast agent are neededImages are subject to blurring due to physiological motion

Stein et al. [42]PAM to study blood oxygenation dynamics of hypoxic cerebral vasculature (mice)Resolution: 70 × 54 μm2None; monitors “endogenous” haemodynamicsNoninvasiveSingle blood vessels can be noninvasively assessed in real time

Struys et al. [43]PETTo characterise acute and long-term vascular and metabolic effects of unilateral common carotid artery occlusion (mice)Resolution: 1.35 mm (transaxial, FWHM), duration: 10 min[15O]H2O and [18F]FDGCan be used to monitor short-term/long-term perfusion and vascular remodelling in ischaemic stroke models
MRIResolution: 98 × 98 μm2, FOV: 2.5 × 2.5 cm2

Tsukada et al. [44]PET to study postischaemic changes (monkeys)Duration: 91 min[18F]flurpiridaz and [18F]BCPP-EFSurgical procedures are invasive and require anaesthesiaStudy metabolic properties and distinguish inflammatory processes

Yanev et al. [45]Steady-state contrast-enhanced MRI to assess the changes in cerebral blood volume and microvascular density after transient stroke (rats)FOV: 30 × 30 mm2, duration: approx. 135 minUltrasmall iron oxide particlesChanges in cerebral blood volume and microvascular density can be observed at least 3 months after stroke; only perfused (and therefore functional) vessels can be detected

Yoon et al. [46]Multiphoton luminescence to visualise morphological changes in cortical vasculature over time (mice)PEG-GNPsPEG-GNPs are highly biocompatibleLong circulation time of PEG-GNPs enables vascular imaging for several hours, making them suitable to observe remodelling

Yu et al. [47]Spectral Doppler OCT to quantitatively assess dynamic blood flow before and after stroke (mice)Duration: approx. 20 minRose bengalMimics ischaemic conditions by reducing CBF in microvasculature; the pulsatility of CBF is quantified; changes in heart rate due to anaesthesia wearing off and being readministered must be considered

Zhang et al. [48]SR-PCI to visualise neural microvasculature (rats)Resolution: <10 μm, FOV: approx. 3 mmNoneHigh doses of ionising radiationVascular architecture and volume can be visualised and quantified; FOV is limited

External sources were not consulted to fill in missing details at this stage in the research. Abbreviations: FOV, field of view; MRI, magnetic resonance imaging; LSCM, laser scanning confocal microscopy; MION, monocrystalline iron oxide nanoparticle; fUS, functional ultrasound; PET, positron emission tomography; VEGFR, vascular endothelial growth factor receptor; PECAM, platelet endothelial cell adhesion molecule; Gd-DTPA, gadolinium-diethylenetriaminepentaacetate; US, ultrasound; CTA, computed tomography-angiography; MRA, magnetic resonance angiography; LSI, laser speckle imaging; RGB, red-green-blue; CBF, cerebral blood flow; FWHM, full width at half maximum; [18F]FDG, [18F]fluorodeoxyglucose; SC-Gd, surface-conjugated gadolinium; PAM, photoacoustic microscopy; SPECT, single-photon emission computed tomography; 99mTc-HMPAO, 99mTc-hexamethylpropyleneamineoxime; BBB, blood-brain barrier; μCT, microcomputed tomography; PEG-GNP, polyethylene glycosylated gold nanoparticle; OCT, optical coherence tomography; SR-PCI, synchrotron radiation phase contrast imaging.

The distribution of the selected publications per year is presented in Figure 4. There evidently appears to have been peaks of relevant research published in 2009, 2014–2015, and 2017 in relation to the search queries for this review, which may indicate a marginally increasing trend in studies of postischaemic neurovascular remodelling in the last 5 years.

4. Discussion

4.1. Rationale

Neurovascular remodelling is a process that establishes an ideal biological environment for neurological healing. Proceeding after an ischaemic injury, neurovascular remodelling acts to restore the haemodynamic stability of the brain, inhibit neural degeneration, eliminate any dead cells by surrounding macrophages, and facilitate the release of growth factors. Many signalling compounds and chemokines are involved in cell–cell interactions to facilitate attempts to salvage surviving neural tissue and reorganise the vasculature following ischaemic injury [17, 49]. A better understanding of these remodelling processes can enhance clinical diagnostics and restorative therapy options; thus, improved visualisation of this vascular reorganisation within the brain is beneficial. These biological pathways involve some of the same molecules that have already been used to inform the development of probes and tracers for the clinical study, such as the glucose analogue [18F]FDG. Nonetheless, there remains a knowledge gap about the biological processes of neurovascular remodelling that can be answered by imaging the regions in which the neurovascular changes occur. Consequently, this review purports itself to identify current imaging technologies being used in neurovascular research to observe postischaemic neurovascular remodelling in small animals. Various techniques were revealed in the published literature and evaluated against a set of properties and common measures in image analysis that were deemed relevant for vascular imaging in the brain. The imaging techniques have been categorised to help identify when certain modalities may be more appropriate for the given purpose. This review provides guidance in the identification of imaging modalities for different translational applications.

4.2. Animal Models of Ischaemia

Small animals play a valuable role in elucidating the mechanisms underlying ischaemia. The use of small animal models allows for greater control and reproducibility to precisely evaluate ischaemic pathophysiology, compared to human cases that involve heterogeneous manifestations and causal factors. Invasive techniques can also be implemented in small animals for direct access to the brain vasculature, although they are undesirable in the context of clinical translatability. Furthermore, animal models allow for the study of immediate postischaemic changes, providing insights into early-stage mechanisms [50]. Some common rodent models of stroke include the (a) middle cerebral artery (MCA) occlusion (MCAo) model, which involves temporarily or permanently disrupting blood flow in the MCA and associated vascular branches that are predominantly affected in human stroke; (b) craniotomy model, which involves craniectomy and removal of a section of dura mater to access the MCA; (c) embolic stroke model, which involves the application of micro/macrospheres or clots to induce ischaemic lesions; (d) endothelin-1 (ET-1) model, which involves the application of ET-1 to a neural region of interest (often the MCA) to act as a vasoconstrictor and thus induce ischaemia; and (e) photothrombosis model, which involves targeted photo-oxidation to generate precise ischaemic lesions [5054]. The most commonly reported ischaemia models in the papers identified in this review were the embolic stroke, MCAo, and craniotomy models (Figure 5). Different stroke models have different advantages and may provide information on different aspects of postischaemic changes; therefore, it is useful to consider the type of information that is desired when designing an imaging study.

4.3. Fundamentals

Neurovascular remodelling undergoes several phases in its process of ultimately establishing fully functional vasculature. To better understand postischaemic changes, studying neurovascular remodelling in its individual stages is ideal. The individual characteristics of these phases can be measured to provide a better understanding of the postischaemic reorganisation that occurs. Firstly, a cellular cascade instigated by endothelial cells causes heightened permeability of vessels due to the deterioration of key vascular junctions. This, in turn, enables the extravasation of plasma proteins, which helps construct a framework for the development of new vessels. Thereafter, the growth of new vasculature leads to fluctuations in haemodynamic properties, such as cerebral blood flow and volume, as well as in vessel density, whilst the vascular network continues to develop. The remapping of the vascular network in response to ischaemia is an important aspect of appreciating neurovascular outcomes [55, 56].

Therefore, it might be of considerable value to utilise small nanometre-scale intravascular contrast agents that could trace this extravasation to signal the generation of new vasculature. Agents of different sizes could help detect different levels of permeability in different areas at different intervals, whilst enhanced opacification could ideally be achieved by utilising a higher density contrast. Ideally, an imaging approach would enable the dynamic visualisation of both large and small vessels as postischaemic angiogenesis proceeds for a more complete picture of the vascular microanatomy, although studying microvascular changes might offer significant information about the earliest postischaemic processes. Hence, to distinguish individual vessels, the image resolution should complement the range of vessel diameters. An imaging resolution of at least 0.5 mm would confer the greatest benefit if the biological tracer being utilised is nonspecific to the vasculature, since cerebral arteries are larger in diameter than this, although a more precise range may be necessary to observe the remodelling of microvessels [5759]. Nevertheless, neurovascular remodelling is not a one-off event; thus, the capacity to obtain repeated measurements over time (i.e., longitudinal imaging) is also desirable in an ideal imaging approach, thereby circumventing the need for more invasive methods. By visualising early processes, studies can infer postischaemic remodelling changes from an earlier time point. This would be valuable in a twofold manner. Firstly, experiments could retain a larger sample size, given the survival durations after ischaemia. Secondly, studying earlier fundamental processes using imaging would allow for better correlations with later outcomes in studies of neurovascular outcomes.

4.4. General Overview of Imaging Modalities

A wide array of imaging techniques have been implemented within the last 10 years in preclinical small animal models specifically for in vivo visualisation of vascular changes following ischaemic injury. Magnetic resonance imaging (MRI) and positron emission tomography (PET) remain the predominant modalities of choice to study postischaemic neurovascular changes, despite the advent of numerous other modalities being implemented over the last 10 years (Figure 5). According to a survey (n = 173) conducted amongst UK and non-UK university researchers and UK National Health Service personnel, MRI is amongst the topmost researched areas [60].

Well-established modalities such as computed tomography (CT), MRI, and PET were expectedly found in the literature; in addition, several other methods have been developed and introduced relatively recently. These include ultrafast ultrasound localisation microscopy (uULM), which incorporates the use of inert gas microbubbles for precise visualisation of cortical vessel branching; synchrotron radiation phase contrast imaging (SR-PCI), which does not require the administration of a contrast agent, but it involves high doses of ionising radiation; the use of gold-coated nanoparticles in multiphoton luminescence to allow for repeated imaging over time (Figure 6); and functional ultrasound (fUS), which can be implemented in freely moving models without the use of contrast agents [16, 20, 46, 48]. Each new imaging modality improves on singular aspects of imaging vascular disease and may likely serve as an adjunct to existing clinical imaging modalities. Given the general accessibility of PET and MRI and their preexisting use in patients, these well-established techniques are likely to persist and receive the bulk of the relevant research focus. Nonetheless, much like PET/CT being a widely available hybrid system, continued study of neurovascular remodelling is likely to rely on more than one technique to develop our understanding and help fine-tune the output data from these large-scale techniques. These novel methods show promise for neurovascular imaging, and it would be of interest to follow any future work involving these methods.

4.5. Imaging Specifications Representing Limitations to Overcome

Multiphoton microscopy is a fluorescence technique that effectively merges laser scanning microscopy with pulsatile multiphoton excitation to image tissues that have been labelled with fluorophores [61]. This approach has been actively employed to investigate the mechanisms of neurovascular reorganisation following ischaemic injury [62]. Despite the high spatial resolution from targeted imaging, this technique suffers from slow imaging times, limited fields of view, and depth of tissue penetration. For example, live imaging in small rodents requires a cranial window—an opening in the skull for optical access to the parenchyma—to be created in the model being tested. This functionally limits the field of view available. In rats, a large cranial window (e.g., 4 × 6 mm2 in size) is usually created, involving removal of the overlying bone and resection of the dura mater, to enable the insertion of devices, such as cannulae and electrodes. This step is complicated by the need to reseal the window to reestablish intracranial pressure and reduce motion artefacts [63]. Mice, on the contrary, are a good alternative because cranial window generation is less invasive than that in rats; the thin skull of mice can remain intact and only requires thinning for a resulting cranial window (e.g., 2 × 2 mm2 in size), which produces limited disruptions in intracranial pressure and decreased inflammation [64]. Therefore, animal choice forms a key part of designing such imaging experiments.

PET and single-photon emission computed tomography (SPECT) are molecular imaging techniques that track biological target-specific changes in function with high sensitivity. Nonetheless, their relatively poor resolution (around 0.8 mm for PET and 0.3 mm for SPECT) prevents anatomically specific imaging and presents as a limiting factor, which may also augment partial volume effects and influence the measurement of vascular parameters. Partial volume effects are a direct response to multiple tissue types present within a single voxel, hence generating image blurring. Partial volume effects refer to the difference between actual and obtained image intensity values and typically occur when more than one type of tissue is contained within individual voxels, ultimately influencing the quantification of key parameters. Larger voxels have a greater probability of containing various tissue types in comparison to smaller voxels. The consequential blurring effects are essentially the result of the interplay between low spatial resolution and limited tissue sampling. Methods to correct for partial volume effects in PET imaging represent an active field of research [6567]. The biggest advantage of using these nuclear medicine techniques despite the poor anatomical definition is that dynamic, real-time imaging becomes possible. Dynamic imaging offers considerable diagnostic information that may not be accessible from static imaging by overcoming the bias presumed by static imaging, in which a single time frame is selected to reflect the overall tracer metabolism without correcting for variabilities in distribution and activity [68]. This advantage of dynamic imaging is important for neurovascular studies when studying absolute blood flow dynamics and the remodelling process.

If anatomical detail is required, MRI provides a complement of both real-time imaging and high spatial resolution without the use of ionising radiation [3]. Access to MRI systems incorporating ultrahigh magnetic fields (i.e., greater than 9.4 T) can allow for the acquisition of images with higher spatial resolution [69]. This enhancement of resolution, however, comes at the cost of increased scan durations. With lengthier scans, the probability of involuntary movements (e.g., cyclic respiration) increases, thus resulting in lower-quality images [57]. An apparently missing imaging technique from the preclinical imaging investigations is functional MRI (fMRI). In patients, these limitations in resolution and real-time imaging have been increasingly overcome by fMRI. Even if this is perhaps one of the most successful imaging modalities in the clinic, its fundamental principle of operation and practical aspects make it largely incompatible for standard imaging of small animals [70].

In general, particularly high-resolution parameters for vascular imaging may be achieved by the newer uULM (Figure 7) and SR-PCI techniques (<10 µm), but also by SPECT (<1 mm), photon excitation microscopy (<1 µm), and angiography (<20 µm); however, the applications of these may come at the cost of longer scanning durations, the use of contrast agents, cranial window generation, or high ionising radiation doses [20, 21, 28, 30, 48, 62]. On the contrary, when a technique is minimally invasive to the subject, the resolution is compromised, as noted with MRI (0.1 mm, <30 mm) and functional photoacoustic microscopy (fPAM; <30 µm) [14, 15, 19, 33, 37, 40, 42, 71, 72]. Researchers have many imaging modalities available to them; however, it is important to understand the limitations of each technology and design experiments based on the limitations of the modalities.

4.6. Contrast Agents and Molecular Probes

Imaging with molecular probes is useful for studying active biological processes at cellular and subcellular levels. Most molecular probes are radionuclide tracers and are used because of their ability to emit radiation from within the body including cells in which these tracers are taken up. As a result, radionuclide imaging offers both qualitative and quantitative data on dynamic biological processes [17, 73]. Meanwhile, contrast agents also emit signals that can enable the collection of qualitative data on the vascular architecture, although there have been discussions regarding their potential side effects [74, 75].

PET is well established as a valuable method to visualise the interplay between changes in cerebral blood flow and the metabolic needs of ischaemic tissues. The effectiveness of PET in understanding different aspects of postischaemic vascular processes depends largely on the types of tracers utilised. For example, [15O]-radiolabelled tracers offer the ability to quantify a number of haemodynamic characteristics, such as cerebral blood flow, cerebral blood volume, cerebral metabolic rate of oxygen, oxygen extraction, and energy metabolism [3]. The most common tracer used in PET imaging is [18F]FDG, although other tracers such as [18F]MISO, [18F]BCPP-EF, and [11C]PK11195 have been utilised as well for different applications [22, 40, 44, 76].

Different molecular factors, such as vascular endothelial growth factor (VEGF), trigger angiogenesis as a component of vascular remodelling, and these processes are regulated by the interplay between components of extracellular matrices and adhesion molecules. VEGF, associated adhesion molecules (e.g., integrins), and microvessel density can thus be useful targets to detect and visualise angiogenesis using probes that are specific to radionuclide imaging techniques [17, 73, 77]. The use of [15O]H2O as a PET tracer was also noted. Although blood oxygen level-dependent fMRI confers better spatial and temporal resolution and reduced radiation exposure, [15O]H2O PET benefits include quantitative data output and the capacity for longitudinal imaging [78]. Accordingly, few [15O]H2O PET studies have been conducted to evaluate cerebral blood flow and other haemodynamics in small animals primarily due to the short half-life of 15O and its potentially high-energy emitted positron, which render the PET images noisier and of lower resolution. Nevertheless, the development of [15O]H2O-based imaging in small animals is an increasing focus of recent research, and the aforementioned challenges may be technically addressed in the near future (more information is available on the website of the project Small Animal Fast MRI Insert at [43, 7982].

Despite the high resolution of MRI, it generally does not require intravenous contrast agent injections; however, MRI may be enhanced by effective contrast agents for visualisation or quantitative analysis, and this can be facilitated by monocrystalline iron oxide nanoparticles (MIONs). MIONs are useful contrast agents because they are relatively cost-effective to produce, nontoxic, biocompatible, and both chemically and physically stable [83]. Although they are able to depict the vascular architecture clearly, it is important to note that utilising MIONs or any intravascular MRI contrast agents may cause difficulties in evaluating vessels with large diameters due to the contrast agent particles reducing the baseline intravascular signals from larger vessels. This suggests that there may exist an upper threshold in studying vascular remodelling using contrast-enhanced MRI and that only small-vessel changes may reliably be observed. This might be an important aspect to consider when assessing vascular remodelling that includes larger vessel sizes and densities [15, 34, 57, 84].

CT methods, such as micro-CT (µCT) and CT angiography, offer detailed images of the neurovascular architecture. Their strengths are reflected in their ability to rapidly generate high-resolution images at relatively low costs [9, 85]. CT angiography involves the administration of an intravenous contrast agent to visualise the vasculature on thin-section images in any plane. Moreover, these detailed images can be obtained in short time frames of approximately less than a minute [21, 39]. Whilst CT does not offer the same degree of soft-tissue resolution as MRI, CT scans are not contraindicated when metal is present. This is uniquely beneficial because animals with implants or devices can still be imaged. For qualitative data on structural changes in the neurovasculature, CT may be a more practical choice of imaging modality, which may require supplementation by other imaging modalities for quantification.

This systematic literature review also revealed a number of techniques that do not require the administration of contrast agents or tracer molecules; these include fUS, photoacoustic microscopy (PAM), fPAM, laser speckle imaging (LSI), and SR-PCI [16, 32, 33, 36, 42, 48]. Evidently, evading the need for intravenous injections would render these techniques as attractive and ideal for translation to clinical practice. LSI has already been implemented to assess systemic microvascular function in patients with and without cardiovascular disease [86]. Meanwhile, PAM has been used previously to evaluate vascular profiles and oxygen saturation in patients with complex regional pain syndrome, as well as to visualise the microvasculature and changes in vascular networks in patients with and without acral melanoma [87, 88].

4.7. Safety Considerations in Small Animals

Depending on the type of study being designed, there are different safety issues to consider. Some optical imaging modalities involve directly exposing cerebral tissue via thinning of the skull or creation of a cerebral window, after which intravascular labels can be monitored as close to the surface as possible [61]. Because of the invasiveness required, in addition to offering comparatively small fields of view due to minimal penetration of tissue, they are commonly employed in small animal preclinical studies [63, 69]. Alternatively, other optical approaches such as fluorescence microscopy offer the ability for repeated imaging longitudinally in the same animals, which circumvents two major problems: (1) needing to sacrifice animals after critical time intervals in a study and (2) using different cohorts of animals for different time points [89]. In this way, noninvasive imaging techniques may allow for longer experiments over a span of several days, weeks, or months with minimal interruption to the animals whilst monitoring dynamic processes like neurovascular remodelling after ischaemic stroke.

Dose-equivalent radiation is another concern. The performance of µCT is influenced by the X-ray source utilised. In preclinical applications, µCT involves significantly lower photon output than that used in clinical CT scanners. Long (e.g., around 50 min) average scan durations may thus be required for preclinical µCT to achieve comparable noise levels to those in clinical CT [90]. Maintaining recovery anaesthesia, restricting movements, and minimising ionising radiation doses over longer periods then become major procedural concerns [39]. The effects of large doses of radiation on such small animals must also be considered. However, a recent study that evaluated X-ray doses and their corresponding biological effects in experimental animals that underwent cone-beam µCT scans demonstrated no significant radiation damage in the animals used [91].

Imaging system design may sometimes dictate animal handling. For example, in MRI studies, no items comprising ferromagnetic metals should be present within an MRI suite; this inflicts limitations on equipment that may be needed for small animals in a given investigation, such as monitoring probes, catheters, needles, metal-containing sutures, or implants. Although shielding from magnetic penetration may be implemented for certain tools, MRI-compatible alternatives are available for instruments that must be present within the MRI suite and within close proximity to the MRI unit [92].

Functional imaging modalities, which reveal physiological changes in response to experimental interventions, mandate stable homeostasis. The administration of anaesthesia may influence key parameters, such as blood volume, flow, and oxygenation; therefore, these changes must be acknowledged and compensated for when administering anaesthetics, analgesics, fluids, body temperature control, blood pressure regulation, or artificial ventilation [27, 9395]. Other considerations when using small animal models arise simply from their small size, which imposes the need for specialised equipment. In experimental models, it is important for stroke to be stimulated under sterile and hygienic conditions to minimise the occurrence of wound infections. It is crucial to verify that any neuroinflammation that is identified using imaging techniques stems from ischaemia, rather than inadequate aseptic methods [96]. Administering sufficient anaesthesia for the duration of the imaging scan, sustaining metabolic homeostasis via dedicated monitoring equipment, and restricted access to the animal during the imaging scan are also prominent aspects that require consideration to ensure that the instruments utilised do not generate image distortions or hazards to the animals or researchers [92].

4.8. Potential Limitations in Imaging Vascular Remodelling

Improving the interpretation of imaging data is an active field of research to overcome the functional limitations present in various imaging techniques. For example, PET produces high-resolution images that are subject to background noise in the data that must be corrected for. Imaging vascular changes using contrast-enhanced methods experiences similar issues. Contrast-enhanced imaging methods rely on the distribution of molecules throughout the vasculature to be visualised. In ischaemic injury, vessel disruption directly affects the distribution of contrast. Acutely, this absence of contrast agents may contribute to the diagnosis of ischaemia; however, in long-term settings, the remodelling itself may contribute to the absence of contrast agents by means of vessel occlusion, haemostasis, or subthreshold quantities of contrast in these vessels, thus limiting detection on image acquisition. This disruption in blood flow is certainly not uncommon in ischaemic injury, and this phenomenon has been previously demonstrated with the use of ultrafast Doppler angiography to study coronary blood flow dynamics [97]. Cerebral blood volume is another concern when assessing neurovascular remodelling because an increase can represent either neoangiogenesis or vessel dilatation [14]. Lack of definition is also an issue to consider when imaging vasculature after injury. The damaged vessels may also allow the contrast agent to leak into the interstitial space around the vessels, which can inevitably distort the resulting images obtained by generating blurred images [98]. Thus, in such cases, certain types of noise in the data could potentially represent vascular leakage or, comprising a more positive outlook, could provide information on changes in postinjury blood flow dynamics.

One overarching aspect that may be worth considering when interpreting images from the translation of preclinical research to its application to humans is the age of animal models used. In general, younger animal models are used for research purposes simply because they are easier to manage and incur lower laboratory costs; older animals would need to be maintained for several months until the equivalent “old age.” However, ischaemic injury in the form of stroke is a much more common occurrence in elderly individuals amongst humans. The ischaemic penumbra also varies in measurements of size and its incorporation into the ischaemic core over time between young and old animals [96]. As a result, it may be worth imaging small animals at various time points into “older” age to inform the interpretation of imaging results in preclinical models. Whether the physiology and pathology of younger preclinical models provide a sufficient platform to develop effective treatments in older humans is a point to consider in future research.

4.9. Future Prospects

The current trends in preclinical imaging are progressing towards synergistic methods, allowing for the simultaneous extraction of the beneficial characteristics of each individual modality, a broader range of information that can be obtained from resulting images, and thus, optimisation of diagnosis. It is difficult to establish a single imaging technique that is optimal in all cases, as this will likely require a trade-off between different parameters; instead, multimodal techniques can be employed to take advantage of the most optimal parameters. Furthermore, with the data obtained from multiple imaging techniques, a greater number of parameters may be integrated into or used to confirm mathematical models to shed further light on physiological and pathological information [69, 73].

A multimodal imaging system with the ability to perform SPECT, bioluminescence imaging, and fluorescence imaging—referred to as the U-SPECT-BioFluo system—was introduced to elucidate physiological and anatomical information within the body, specifically to target tumours. To achieve this, mouse models were administered with both a fluorescent optical dye and radioactive agent to visualise their molecular-level interactions within the body. This imaging system was originally introduced with specific relevance to study tumourigenic angiogenesis, and similarly, such a system could be employed to study the vascular changes (which also involve angiogenesis, amongst other cellular processes) following ischaemic injury (Figure 8) [99]. On a similar note, another group developed a hexamodal imaging system that exploited a unique porphyrin-phospholipid-coated type of nanoparticle. These nanoparticulate agents can be utilised to retrieve information from six different imaging modalities that comprise this system: upconversion, fluorescence, photoacoustic, PET, CT, and Cherenkov luminescence imaging [100]. Highly integrated systems such as this show great promise and feasibility for providing information that may not be achievable with single or dual imaging modalities. Multimodal neuroimaging hence represents the foundation for advancing postischaemic restorative therapies. Combinatorial techniques can ultimately be implemented to achieve a more needs-based and personalised approach in medicine and healthcare.

Novel tracers that target different molecular pathways and can be utilised with existing imaging systems are also continuously under investigation. For example, the newly characterised PET tracer [18F]glycoprotein-1 ([18F]GP1) has been demonstrated to elucidate regions of platelet aggregation and thrombi in cynomolgus monkeys. Small venous and arterial thrombi were clearly and simply visualised in real time, and the tracer exhibited rapid blood clearance, raising the possibility of imaging ischaemia-related vascular changes in humans using [18F]GP1 (Figure 9) [101]. In addition, another group demonstrated the feasibility of a dual optical and PET/CT tracer for (a) noninvasive in vivo imaging of activated macrophages and vascular inflammatory activity in atherosclerotic plaques in mouse models and (b) visualisation of activated macrophages in human carotid plaque tissues, based on the activity of cysteine cathepsins [102].

Developments in MRI systems that may be useful in cases of ischaemia are also worth mentioning here. Four-dimensional (4D) flow MRI has been demonstrated to be useful for the evaluation of neurovascular haemodynamics and cerebral blood flow [103, 104]. Although long acquisition times (approx. 5–20 min) and a spatial resolution that is insufficient to capture small-vessel haemodynamics represent considerable technical limitations, 4D flow MRI comes with the benefit of evading the necessity for gadolinium contrast agents [105]. To achieve superior image contrast, MRI-based quantitative susceptibility-weighted imaging offers a way to facilitate the delineation of neural structures with the added advantage of quantification of magnetic properties in the brain [83]. Ultimately, preclinical imaging is performed with the aim of translating findings to clinical practice. Given the fact that the most common preclinical imaging techniques are MRI followed by PET, as identified in this systematic literature review, their direct combination in dedicated PET/MRI systems can prove to be advantageous for providing complementary functional and structural data. This would be advantageous for studying ongoing vascular changes; however, technical developments are warranted to facilitate accurate quantification and improved spatiotemporal resolution [106, 107].

Through its wide-ranging applications, preclinical imaging generously lends itself to translational approaches from small animals to humans. The ability to visualise tissues and organs influences the precision and accuracy of diagnosis, staging, treatment planning, and treatment response evaluation. MRI, PET, SPECT, CT, and ultrasound are commonly used in clinical practice for various imaging purposes. Although optical imaging modalities are relatively not as frequently implemented in the clinic, they are increasingly garnering attention for clinical translation [108]. The Network for Translational Research: Optical Imaging in Multimodal Platforms is a programme dedicated to developing, optimising, and validating imaging methods for rapid clinical translation. In particular, this network focusses on early-stage imaging using multiple common modalities in combination with an optical imaging modality; this combination may facilitate a quicker progression of optical imaging modalities to clinical trials [109, 110].

Furthermore, multidisciplinary collaboration can prove to enhance the value of imaging technology in translating preclinical animal models to clinical settings. For example, point-of-care technology is emerging as the future direction for clinical applications of imaging to enhance patients’ experiences and decrease associated expenses. The most significant advantage of point-of-care medical imaging is the capacity to provide instant information to guide immediate clinical management decisions, as it acts as a first-line tool to screen for acute medical problems, particularly in resource-limited settings [60]. Ultimately, optimal medical and molecular imaging methods may contribute to more accurate diagnoses at earlier disease stages and prior to and during surgical operations; in due course, these methods are anticipated to enhance therapeutic outcomes in patients.

5. Conclusions

The field of neuroimaging has augmented our understanding of the mechanisms of ischaemic trauma, and a variety of imaging techniques are particularly helpful for observing subsequent vascular remodelling within the brain. Appropriate combinations of imaging modalities incorporating biomarkers of blood flow, energy fluctuations, and neurovascular breakdown can potentially elucidate optimal perspectives of postischaemic reorganisation.

This review is a systematic study and analysis of the literature published between 2008 and 2018 regarding preclinical in vivo imaging biomarkers for postischaemia neurovascular remodelling. The search identified 35 peer-reviewed research articles, which predominantly reported on the use of MRI or PET, although other imaging modalities were also utilised. There remain critical gaps in our knowledge within the field of restorative therapy for neurological pathologies, such as traumatic brain injury and ischaemia; amongst them, being able to detect vascular remodelling noninvasively and observe its evolution through stages of vascular recovery is an important aspect. The push towards molecular imaging has promoted the development of biological target-specific tracers to reveal the physiological and pathological mechanisms within the brain. Concurrently, the prospect of multimodality clinical imaging with its unification of anatomical and functional information holds superior potential in expanding our understanding of neurovascular organisation and disease activity.

Conflicts of Interest

The authors have no conflicts of interest to disclose, and they reported all papers that satisfied the specified relevant criteria; however, if some papers are missing, this was not intentional and they wish to proactively apologise to any corresponding authors.


This study was supported by the Engineering and Physical Sciences Research Council (EPSRC) Center for Doctoral Training in Tissue Engineering and Regenerative Medicine (EP/L014823/1).


  1. E. Taoufik and L. Probert, “Ischemic neuronal damage,” Current Pharmaceutical Design, vol. 14, no. 33, pp. 3565–3573, 2008. View at: Publisher Site | Google Scholar
  2. K. Arai, G. Jin, D. Navaratna, and E. H. Lo, “Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke,” FEBS Journal, vol. 276, no. 17, pp. 4644–4652, 2009. View at: Publisher Site | Google Scholar
  3. P. Barber, “Magnetic resonance imaging of ischemia viability thresholds and the neurovascular unit,” Sensors, vol. 13, no. 6, pp. 6981–7003, 2013. View at: Publisher Site | Google Scholar
  4. A. Sachdev, R. Sharma, and D. Gupta, “Cerebrovascular complications in pediatric intensive care unit,” Indian Journal of Critical Care Medicine, vol. 14, no. 3, pp. 129–140, 2010. View at: Publisher Site | Google Scholar
  5. Y. Xiong, A. Mahmood, and M. Chopp, “Angiogenesis, neurogenesis and brain recovery of function following injury,” Current Opinion in Investigational Drugs, vol. 11, no. 3, pp. 298–308, 2010. View at: Google Scholar
  6. J. Boltze, C. Kleinschnitz, K. G. Reymann et al., “Neurovascular pathophysiology in cerebral ischemia, dementia and the ageing brain–current trends in basic, translational and clinical research,” Experimental & Translational Stroke Medicine, vol. 4, no. 1, p. 14, 2012. View at: Publisher Site | Google Scholar
  7. A. Popa-Wagner, D. Pirici, E. Bogdan Petcu et al., “Pathophysiology of the vascular wall and its relevance for cerebrovascular disorders in aged rodents,” Current Neurovascular Research, vol. 7, no. 3, pp. 251–267, 2010. View at: Publisher Site | Google Scholar
  8. K. S. Kamalian S, D. J. Boulter, M. H. Lev, R. G. Gonzalez, and P. W. Schaefer, “Stroke differential diagnosis and mimics: part 1,” Applied Radiology, vol. 44, no. 11, pp. 26–39, 2015. View at: Google Scholar
  9. A. Dorr, J. G. Sled, and N. Kabani, “Three-dimensional cerebral vasculature of the CBA mouse brain: a magnetic resonance imaging and micro computed tomography study,” Neuroimage, vol. 35, no. 4, pp. 1409–1423, 2007. View at: Publisher Site | Google Scholar
  10. R. S. J. Frackowiak, G.-L. Lenzi, T. Jones, and J. D. Heather, “Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography,” Journal of Computer Assisted Tomography, vol. 4, no. 6, pp. 727–736, 1980. View at: Publisher Site | Google Scholar
  11. T. Jones, D. A. Chesler, and M. M. Ter-Pogossian, “The continuous inhalation of oxygen-15 for assessing regional oxygen extraction in the brain of man,” British Journal of Radiology, vol. 49, no. 580, pp. 339–343, 1976. View at: Publisher Site | Google Scholar
  12. H.-Y. Wey, V. R. Desai, and T. Q. Duong, “A review of current imaging methods used in stroke research,” Neurological Research, vol. 35, no. 10, pp. 1092–1102, 2013. View at: Publisher Site | Google Scholar
  13. D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, and for the PRISMA Group, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” BMJ, vol. 339, no. 1, Article ID b2535, 2009. View at: Publisher Site | Google Scholar
  14. A. Bosomtwi, Q. Jiang, G. L. Ding et al., “Quantitative evaluation of microvascular density after stroke in rats using MRI,” Journal of Cerebral Blood Flow & Metabolism, vol. 28, no. 12, pp. 1978–1987, 2008. View at: Publisher Site | Google Scholar
  15. A. Bosomtwi, M. Chopp, L. Zhang et al., “Mean microvessel segment length and radius after embolic stroke: comparison of magnetic resonance imaging (MRI) and laser scanning confocal microscopy (LSCM),” Brain Research, vol. 1381, pp. 217–227, 2011. View at: Publisher Site | Google Scholar
  16. C. Brunner, C. Isabel, A. Martin et al., “Mapping the dynamics of brain perfusion using functional ultrasound in a rat model of transient middle cerebral artery occlusion,” Journal of Cerebral Blood Flow & Metabolism, vol. 37, no. 1, pp. 263–276, 2017. View at: Publisher Site | Google Scholar
  17. W. Cai, R. Guzman, A. R. Hsu et al., “Positron emission tomography imaging of poststroke angiogenesis,” Stroke, vol. 40, no. 1, pp. 270–277, 2009. View at: Publisher Site | Google Scholar
  18. L. H. Deddens, G. A. van Tilborg, A. van der Toorn, H. E. de Vries, and R. M. Dijkhuizen, “PECAM-1-targeted micron-sized particles of iron oxide as MRI contrast agent for detection of vascular remodeling after cerebral ischemia,” Contrast Media & Molecular Imaging, vol. 8, no. 5, pp. 393–401, 2013. View at: Publisher Site | Google Scholar
  19. G. Ding, Q. Jiang, L. Li et al., “Angiogenesis detected after embolic stroke in rat brain using magnetic resonance T2∗WI,” Stroke, vol. 39, no. 5, pp. 1563–1568, 2008. View at: Publisher Site | Google Scholar
  20. C. Errico, J. Pierre, S. Pezet et al., “Ultrafast ultrasound localization microscopy for deep super-resolution vascular imaging,” Nature, vol. 527, no. 7579, pp. 499–502, 2015. View at: Publisher Site | Google Scholar
  21. G. Figueiredo, C. Brockmann, H. Boll et al., “Comparison of digital subtraction angiography, micro-computed tomography angiography and magnetic resonance angiography in the assessment of the cerebrovascular system in live mice,” Clinical Neuroradiology, vol. 22, no. 1, pp. 21–28, 2012. View at: Publisher Site | Google Scholar
  22. M. Gramer, D. Feuerstein, A. Steimers et al., “Device for simultaneous positron emission tomography, laser speckle imaging and RGB reflectometry: validation and application to cortical spreading depression and brain ischemia in rats,” Neuroimage, vol. 94, pp. 250–262, 2014. View at: Publisher Site | Google Scholar
  23. N. G. Horton, K. Wang, D. Kobat et al., “In vivo three-photon microscopy of subcortical structures within an intact mouse brain,” Nature Photonics, vol. 7, no. 3, pp. 205–209, 2013. View at: Publisher Site | Google Scholar
  24. G. P. Howles, K. B. Ghaghada, Y. Qi, S. Mukundan, and G. A. Johnson, “High-resolution magnetic resonance angiography in the mouse using a nanoparticle blood-pool contrast agent,” Magnetic Resonance in Medicine, vol. 62, no. 6, pp. 1447–1456, 2009. View at: Publisher Site | Google Scholar
  25. S. Hu, K. Maslov, and L. V. Wang, “Noninvasive label-free imaging of microhemodynamics by optical-resolution photoacoustic microscopy,” Optics Express, vol. 17, no. 9, pp. 7688–7693, 2009. View at: Publisher Site | Google Scholar
  26. C.-H. Huang, Y.-Y. lan Shih, T.-Y. Siow et al., “Temporal assessment of vascular reactivity and functionality using MRI during postischemic proangiogenenic vascular remodelling,” Magnetic Resonance Imaging, vol. 33, no. 7, pp. 903–910, 2015. View at: Publisher Site | Google Scholar
  27. E. Jimenez-Xarrie, B. Perez, A. P. Dantas et al., “Uric acid treatment after stroke prevents long-term middle cerebral artery remodelling and attenuates brain damage in spontaneously hypertensive rats,” Translational Stroke Research, 2018, In press. View at: Publisher Site | Google Scholar
  28. A. Kolodziej, M. Lippert, F. Angenstein et al., “SPECT-imaging of activity-dependent changes in regional cerebral blood flow induced by electrical and optogenetic self-stimulation in mice,” Neuroimage, vol. 103, pp. 171–180, 2014. View at: Publisher Site | Google Scholar
  29. E. M. R. Lake, P. Bazzigaluppi, J. Mester et al., “Neurovascular unit remodelling in the subacute stage of stroke recovery,” NeuroImage, vol. 146, pp. 869–882, 2017. View at: Publisher Site | Google Scholar
  30. J. Lecoq, A. Parpaleix, E. Roussakis et al., “Simultaneous two-photon imaging of oxygen and blood flow in deep cerebral vessels,” Nature Medicine, vol. 17, no. 7, pp. 893–898, 2011. View at: Publisher Site | Google Scholar
  31. A. Letourneur, V. Chen, G. Waterman, and P. J. Drew, “A method for longitudinal, transcranial imaging of blood flow and remodeling of the cerebral vasculature in postnatal mice,” Physiological Reports, vol. 2, no. 12, Article ID e12238, 2014. View at: Publisher Site | Google Scholar
  32. N. Li, X. Jia, K. Murari et al., “High spatiotemporal resolution imaging of the neurovascular response to electrical stimulation of rat peripheral trigeminal nerve as revealed by in vivo temporal laser speckle contrast,” Journal of Neuroscience Methods, vol. 176, no. 2, pp. 230–236, 2009. View at: Publisher Site | Google Scholar
  33. L. D. Liao, C. T. Lin, Y. Y. Shih et al., “Investigation of the cerebral hemodynamic response function in single blood vessels by functional photoacoustic microscopy,” Journal of Biomedical Optics, vol. 17, no. 6, Article ID 061210, 2012. View at: Publisher Site | Google Scholar
  34. C. Y. Lin, M. H. Lin, W. M. Cheung et al., “In vivo cerebromicrovasculatural visualization using 3D DeltaR2-based microscopy of magnetic resonance angiography (3DDeltaR2-mMRA),” Neuroimage, vol. 45, no. 3, pp. 824–831, 2009. View at: Publisher Site | Google Scholar
  35. J. Luckl, W. Baker, Z.H. Sun, T. Durduran, A. G. Yodh, and J. H. Greenberg, “The biological effect of contralateral forepaw stimulation in rat focal cerebral ischemia: a multispectral optical imaging study,” Frontiers in Neurogenetics, vol. 2, p. 19, 2010. View at: Publisher Site | Google Scholar
  36. P. Miao, A. Rege, N. Li, N. V. Thakor, and S. Tong, “High resolution cerebral blood flow imaging by registered laser speckle contrast analysis,” IEEE Transactions on Biomedical Engineering, vol. 57, no. 5, pp. 1152–1157, 2010. View at: Publisher Site | Google Scholar
  37. T. N. Nagaraja, K. Karki, J. R. Ewing, R. L. Croxen, and R. A. Knight, “Identification of variations in blood-brain barrier opening after cerebral ischemia by dual contrast-enhanced magnetic resonance imaging and T 1sat measurements,” Stroke, vol. 39, no. 2, pp. 427–432, 2008. View at: Publisher Site | Google Scholar
  38. S. Sakadžić, E. Roussakis, M. A. Yaseen et al., “Two photon imaging of the oxygen partial pressure in cerebral microvasculature,” Nature Methods, vol. 7, no. 9, pp. 755–759, 2010. View at: Publisher Site | Google Scholar
  39. S. J. Schambach, S. Bag, V. Steil et al., “Ultrafast high-resolution in vivo volume-CTA of mice cerebral vessels,” Stroke, vol. 40, no. 4, pp. 1444–1450, 2009. View at: Publisher Site | Google Scholar
  40. M. Schroeter, M. A. Dennin, M. Walberer et al., “Neuroinflammation extends brain tissue at risk to vital peri-infarct tissue: a double tracer [11C]PK11195- and [18F]FDG-PET study,” Journal of Cerebral Blood Flow & Metabolism, vol. 29, no. 6, pp. 1216–1225, 2009. View at: Publisher Site | Google Scholar
  41. Y. Seo, T. Hashimoto, Y. Nuki, and B. H. Hasegawa, “In vivo microCT imaging of rodent cerebral vasculature,” Physics in Medicine & Biology, vol. 53, no. 7, pp. N99–N107, 2008. View at: Publisher Site | Google Scholar
  42. E. W. Stein, K. Maslov, and L. V. Wang, “Noninvasive, in vivo imaging of blood-oxygenation dynamics within the mouse brain using photoacoustic microscopy,” Journal of Biomedical Optics, vol. 14, no. 2, Article ID 020502, 2009. View at: Publisher Site | Google Scholar
  43. T. Struys, K. Govaerts, W. Oosterlinck et al., “In vivo evidence for long-term vascular remodeling resulting from chronic cerebral hypoperfusion in mice,” Journal of Cerebral Blood Flow & Metabolism, vol. 37, no. 2, pp. 726–739, 2017. View at: Publisher Site | Google Scholar
  44. H. Tsukada, H. Ohba, S. Nishiyama et al., “PET imaging of ischemia-induced impairment of mitochondrial complex I function in monkey brain,” Journal of Cerebral Blood Flow & Metabolism, vol. 34, no. 4, pp. 708–714, 2014. View at: Publisher Site | Google Scholar
  45. P. Yanev, P. R. Seevinck, U. S. Rudrapatna et al., “Magnetic resonance imaging of local and remote vascular remodelling after experimental stroke,” Journal of Cerebral Blood Flow & Metabolism, vol. 37, no. 8, pp. 2768–2779, 2017. View at: Publisher Site | Google Scholar
  46. H.-J. Yoon, E.-S. Lee, M. Kang, Y. Jeong, and J.-H. Park, “In vivo multi-photon luminescence imaging of cerebral vasculature and blood–brain barrier integrity using gold nanoparticles,” Journal of Materials Chemistry B, vol. 3, no. 15, pp. 2935–2938, 2015. View at: Publisher Site | Google Scholar
  47. L. Yu, E. Nguyen, G. Liu, B. Choi, and Z. Chen, “Spectral Doppler optical coherence tomography imaging of localized ischemic stroke in a mouse model,” Journal of Biomedical Optics, vol. 15, no. 6, Article ID 066006, 2010. View at: Publisher Site | Google Scholar
  48. M. Q. Zhang, L. Zhou, Q. F. Deng et al., “Ultra-high-resolution 3D digitalized imaging of the cerebral angioarchitecture in rats using synchrotron radiation,” Scientific Reports, vol. 5, Article ID 14982, 2015. View at: Publisher Site | Google Scholar
  49. D. M. Hermann, A. M. Buga, and A. Popa-Wagner, “Neurovascular remodeling in the aged ischemic brain,” Journal of Neural Transmission, vol. 122, no. 1, pp. S25–S33, 2015. View at: Publisher Site | Google Scholar
  50. F. Fluri, M. K. Schuhmann, and C. Kleinschnitz, “Animal models of ischemic stroke and their application in clinical research,” Drug Design, Development and Therapy, vol. 9, p. 3445, 2015. View at: Publisher Site | Google Scholar
  51. F. Liu and L. D. McCullough, “Middle cerebral artery occlusion model in rodents: methods and potential pitfalls,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 464701, 9 pages, 2011. View at: Publisher Site | Google Scholar
  52. M. Walberer and M. A. Rueger, “The macrosphere model-an embolic stroke model for studying the pathophysiology of focal cerebral ischemia in a translational approach,” Annals of Translational Medicine, vol. 3, no. 9, p. 123, 2015. View at: Google Scholar
  53. H. C. S. Abeysinghe, L. Bokhari, G. J. Dusting, and C. L. Roulston, “Brain remodelling following endothelin-1 induced stroke in conscious rats,” PLoS One, vol. 9, no. 5, Article ID e97007, 2014. View at: Publisher Site | Google Scholar
  54. A. B. Uzdensky, “Photothrombotic stroke as a model of ischemic stroke,” Translational Stroke Research, vol. 9, no. 5, pp. 437–451, 2017. View at: Publisher Site | Google Scholar
  55. P. Carmeliet, “Mechanisms of angiogenesis and arteriogenesis,” Nature Medicine, vol. 6, no. 4, pp. 389–395, 2000. View at: Publisher Site | Google Scholar
  56. M. A. Font, A. Arboix, and J. Krupinski, “Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke,” Current Cardiology Reviews, vol. 6, no. 3, pp. 238–44, 2010. View at: Publisher Site | Google Scholar
  57. P. J. Bolan, E. Yacoub, M. Garwood, K. Ugurbil, and N. Harel, “In vivo micro-MRI of intracortical neurovasculature,” Neuroimage, vol. 32, no. 1, pp. 62–69, 2006. View at: Publisher Site | Google Scholar
  58. R. Gupta, S. E. Jones, E. A. Q. Mooyaart, and S. R. Pomerantz, “Computed tomographic angiography in stroke imaging: fundamental principles, pathologic findings, and common pitfalls,” Seminars in Ultrasound, CT and MRI, vol. 27, no. 3, pp. 221–242, 2006. View at: Publisher Site | Google Scholar
  59. M. A. Stefani, F. L. Schneider, A. C. H. Marrone, A. G. Severino, A. P. Jackowski, and M. C. Wallace, “Anatomic variations of anterior cerebral artery cortical branches,” Clinical Anatomy, vol. 13, no. 4, pp. 231–236, 2000. View at: Publisher Site | Google Scholar
  60. EPSRC, Report of the Medical Imaging Technology Working Group, EPSRC, Swindon, UK, 2012.
  61. P. Yanev and R. M. Dijkhuizen, “In vivo imaging of neurovascular remodeling after stroke,” Stroke, vol. 43, no. 12, pp. 3436–3441, 2012. View at: Publisher Site | Google Scholar
  62. C. E. Brown, P. Li, J. D. Boyd, K. R. Delaney, and T. H. Murphy, “Extensive turnover of dendritic spines and vascular remodeling in cortical tissues recovering from stroke,” Journal of Neuroscience, vol. 27, no. 15, pp. 4101–4109, 2007. View at: Publisher Site | Google Scholar
  63. A. Y. Shih, J. D. Driscoll, P. J. Drew et al., “Two-photon microscopy as a tool to study blood flow and neurovascular coupling in the rodent brain,” Journal of Cerebral Blood Flow & Metabolism, vol. 32, no. 7, pp. 1277–1309, 2012. View at: Publisher Site | Google Scholar
  64. P. J. Drew, A. Y. Shih, J. D. Driscoll et al., “Chronic optical access through a polished and reinforced thinned skull,” Nature Methods, vol. 7, no. 12, pp. 981–984, 2010. View at: Publisher Site | Google Scholar
  65. E. Kim, M. Shidahara, C. Tsoumpas et al., “Partial volume correction using structural-functional synergistic resolution recovery: comparison with geometric transfer matrix method,” Journal of Cerebral Blood Flow & Metabolism, vol. 33, no. 6, pp. 914–920, 2013. View at: Publisher Site | Google Scholar
  66. M. Soret, S. L. Bacharach, and I. Buvat, “Partial-volume effect in PET tumor imaging,” Journal of Nuclear Medicine, vol. 48, no. 6, pp. 932–945, 2007. View at: Publisher Site | Google Scholar
  67. J. Tohka, “Partial volume effect modeling for segmentation and tissue classification of brain magnetic resonance images: a review,” World Journal of Radiology, vol. 6, no. 11, pp. 855–864, 2014. View at: Publisher Site | Google Scholar
  68. M. Muzi, F. O'Sullivan, D. A. Mankoff et al., “Quantitative assessment of dynamic PET imaging data in cancer imaging,” Magnetic Resonance Imaging, vol. 30, no. 9, pp. 1203–1215, 2012. View at: Publisher Site | Google Scholar
  69. A. P. Pathak, E. Kim, J. Zhang, and M. V. Jones, “Three-dimensional imaging of the mouse neurovasculature with magnetic resonance microscopy,” PLoS One, vol. 6, no. 7, Article ID e22643, 2011. View at: Publisher Site | Google Scholar
  70. A. Van der Linden, N. Van Camp, P. Ramos-Cabrer, and M. Hoehn, “Current status of functional MRI on small animals: application to physiology, pathophysiology, and cognition,” NMR Biomedicine, vol. 20, no. 5, pp. 522–545, 2007. View at: Publisher Site | Google Scholar
  71. Q. Jiang, Z. G. Zhang, G. L. Ding et al., “Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI,” Neuroimage, vol. 28, no. 3, pp. 698–707, 2005. View at: Publisher Site | Google Scholar
  72. R. Weber, S. Wegener, P. Ramos-Cabrer, D. Wiedermann, and M. Hoehn, “MRI detection of macrophage activity after experimental stroke in rats: new indicators for late appearance of vascular degradation?” Magnetic Resonance in Medicine, vol. 54, no. 1, pp. 59–66, 2005. View at: Publisher Site | Google Scholar
  73. L. W. Dobrucki and A. J. Sinusas, “PET and SPECT in cardiovascular molecular imaging,” Nature Reviews Cardiology, vol. 7, no. 1, pp. 38–47, 2010. View at: Publisher Site | Google Scholar
  74. S. P. Lin and J. J. Brown, “MR contrast agents: physical and pharmacologic basics,” Journal of Magnetic Resonance Imaging, vol. 25, no. 5, pp. 884–899, 2007. View at: Publisher Site | Google Scholar
  75. E. Hernandez-Torres, N. Kassner, N. D. Forkert et al., “Anisotropic cerebral vascular architecture causes orientation dependency in cerebral blood flow and volume measured with dynamic susceptibility contrast magnetic resonance imaging,” Journal of Cerebral Blood Flow & Metabolism, vol. 37, no. 3, pp. 1108–1119, 2017. View at: Publisher Site | Google Scholar
  76. M. Takasawa, J. S. Beech, T. D. Fryer et al., “Imaging of brain hypoxia in permanent and temporary middle cerebral artery occlusion in the rat using 18F-fluoromisonidazole and positron emission tomography: a pilot study,” Journal of Cerebral Blood Flow & Metabolism, vol. 27, no. 4, pp. 679–689, 2007. View at: Publisher Site | Google Scholar
  77. A. Surov, H. J. Meyer, and A. Wienke, “Standardized uptake values derived from (18)F-FDG PET may predict lung cancer microvessel density and expression of KI 67, VEGF, and HIF-1alpha but not expression of cyclin D1, PCNA, EGFR, PD L1, and p53,” Contrast Media & Molecular Imaging, vol. 2018, Article ID 9257929, 10 pages, 2018. View at: Publisher Site | Google Scholar
  78. M. Kameyama, K. Murakami, and M. Jinzaki, “Comparison of [(15)O] H2O positron emission tomography and functional magnetic resonance imaging in activation studies,” World Journal of Nuclear Medicine, vol. 15, no. 1, pp. 3–6, 2016. View at: Google Scholar
  79. T. Temma, M. Yamazaki, J. Miyanohara et al., “Sequential PET estimation of cerebral oxygen metabolism with spontaneous respiration of (15)O-gas in mice with bilateral common carotid artery stenosis,” Journal of Cerebral Blood Flow & Metabolism, vol. 37, no. 10, pp. 3334–3343, 2017. View at: Publisher Site | Google Scholar
  80. G. Horitsugi, T. Watabe, Y. Kanai et al., “Oxygen-15 labeled CO(2), O(2), and CO PET in small animals: evaluation using a 3D-mode microPET scanner and impact of reconstruction algorithms,” EJNMMI Research, vol. 7, no. 1, p. 91, 2017. View at: Publisher Site | Google Scholar
  81. M. Kobayashi, T. Mori, Y. Kiyono et al., “Cerebral oxygen metabolism of rats using injectable (15)O-oxygen with a steady-state method,” Journal of Cerebral Blood Flow & Metabolism, vol. 32, no. 1, pp. 33–40, 2012. View at: Publisher Site | Google Scholar
  82. X. Zhang, Y. Petibon, A. Sitek et al., “In-vivo simultaneous DCE-MRI/O-15-water-PET,” Journal of Nuclear Medicine, vol. 56, no. 3, p. 644, 2015. View at: Google Scholar
  83. H. Wei, L. Xie, R. Dibb et al., “Imaging whole-brain cytoarchitecture of mouse with MRI-based quantitative susceptibility mapping,” Neuroimage, vol. 137, pp. 107–115, 2016. View at: Publisher Site | Google Scholar
  84. N. Harel, J. Lin, S. Moeller, K. Ugurbil, and E. Yacoub, “Combined imaging-histological study of cortical laminar specificity of fMRI signals,” Neuroimage, vol. 29, no. 3, pp. 879–887, 2006. View at: Publisher Site | Google Scholar
  85. S. J. Schambach, S. Bag, C. Groden, L. Schilling, and M. A. Brockmann, “Vascular imaging in small rodents using micro-CT,” Methods, vol. 50, no. 1, pp. 26–35, 2010. View at: Publisher Site | Google Scholar
  86. J. P. Borges, G. O. Lopes, V. Verri et al., “A novel effective method for the assessment of microvascular function in male patients with coronary artery disease: a pilot study using laser speckle contrast imaging,” Brazilian Journal of Medical and Biological Research, vol. 49, no. 10, Article ID e5541, 2016. View at: Publisher Site | Google Scholar
  87. C. P. Favazza, O. Jassim, L. A. Cornelius, and L. V. Wang, “In vivo photoacoustic microscopy of human cutaneous microvasculature and a nevus,” Journal of Biomedical Optics, vol. 16, no. 1, Article ID 016015, 2011. View at: Publisher Site | Google Scholar
  88. Y. Zhou, X. Yi, W. Xing et al., “Microcirculatory changes identified by photoacoustic microscopy in patients with complex regional pain syndrome type I after stellate ganglion blocks,” Journal of Biomedical Optics, vol. 19, no. 8, Article ID 086017, 2014. View at: Publisher Site | Google Scholar
  89. Y. Tomita, N. Kubis, Y. Calando et al., “Long-term in vivo investigation of mouse cerebral microcirculation by fluorescence confocal microscopy in the area of focal ischemia,” Journal of Cerebral Blood Flow & Metabolism, vol. 25, no. 7, pp. 858–867, 2005. View at: Publisher Site | Google Scholar
  90. D. P. Clark and C. T. Badea, “Micro-CT of rodents: state-of-the-art and future perspectives,” Physica Medica, vol. 30, no. 6, pp. 619–634, 2014. View at: Publisher Site | Google Scholar
  91. N. Miyahara, T. Kokubo, Y. Hara et al., “Evaluation of X-ray doses and their corresponding biological effects on experimental animals in cone-beam micro-CT scans (R-mCT2),” Radiological Physics and Technology, vol. 9, no. 1, pp. 60–68, 2016. View at: Publisher Site | Google Scholar
  92. L. A. Colby and B. J. Morenko, “Clinical considerations in rodent bioimaging,” Comparative Medicine, vol. 54, no. 6, pp. 623–630, 2004. View at: Google Scholar
  93. C. Broux, I. Tropres, O. Montigon et al., “The effects of sustained hyperventilation on regional cerebral blood volume in thiopental-anesthetized rats,” Anesthesia & Analgesia, vol. 95, no. 6, pp. 1746–1751, 2002. View at: Publisher Site | Google Scholar
  94. J. N. Lorenz, “A practical guide to evaluating cardiovascular, renal, and pulmonary function in mice,” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 282, no. 6, pp. R1565–1582, 2002. View at: Publisher Site | Google Scholar
  95. A. H. Moore, C. L. Osteen, A. F. Chatziioannou, D. A. Hovda, and S. R. Cherry, “Quantitative assessment of longitudinal metabolic changes in vivo after traumatic brain injury in the adult rat using FDG-microPET,” Journal of Cerebral Blood Flow & Metabolism, vol. 20, no. 10, pp. 1492–1501, 2000. View at: Publisher Site | Google Scholar
  96. I. M. Macrae, “Preclinical stroke research--advantages and disadvantages of the most common rodent models of focal ischaemia,” British Journal of Pharmacology, vol. 164, no. 4, pp. 1062–1078, 2011. View at: Publisher Site | Google Scholar
  97. D. Maresca, M. Correia, O. Villemain et al., “Noninvasive imaging of the coronary vasculature using ultrafast ultrasound,” JACC: Cardiovascular Imaging, vol. 11, no. 6, pp. 798–808, 2018. View at: Publisher Site | Google Scholar
  98. Y. Zhao, I. J. C. MacCormick, D. G. Parry et al., “Automated detection of leakage in fluorescein angiography images with application to malarial retinopathy,” Scientific Reports, vol. 5, Article ID 10425, 2015. View at: Publisher Site | Google Scholar
  99. M. N. van Oosterom, R. Kreuger, T. Buckle et al., “U-SPECT-BioFluo: an integrated radionuclide, bioluminescence, and fluorescence imaging platform,” EJNMMI Research, vol. 4, no. 1, p. 56, 2014. View at: Publisher Site | Google Scholar
  100. J. Rieffel, F. Chen, J. Kim et al., “Hexamodal imaging with porphyrin-phospholipid-coated upconversion nanoparticles,” Advanced Materials, vol. 27, no. 10, pp. 1785–1790, 2015. View at: Publisher Site | Google Scholar
  101. J. Lohrke, H. Siebeneicher, M. Berger et al., “18)F-GP1, a novel PET tracer designed for high-sensitivity, low-background detection of thrombi,” Journal of Nuclear Medicine, vol. 58, no. 7, pp. 1094–1099, 2017. View at: Publisher Site | Google Scholar
  102. N. P. Withana, T. Saito, X. Ma et al., “Dual-modality activity-based probes as molecular imaging agents for vascular inflammation,” Journal of Nuclear Medicine, vol. 57, no. 10, pp. 1583–1590, 2016. View at: Publisher Site | Google Scholar
  103. F. Schuchardt, L. Schroeder, C. Anastasopoulos et al., “In vivo analysis of physiological 3D blood flow of cerebral veins,” European Radiology, vol. 25, no. 8, pp. 2371–2380, 2015. View at: Publisher Site | Google Scholar
  104. E. M. Schrauben, K. M. Johnson, J. Huston et al., “Reproducibility of cerebrospinal venous blood flow and vessel anatomy with the use of phase contrast-vastly undersampled isotropic projection reconstruction and contrast-enhanced MRA,” American Journal of Neuroradiology, vol. 35, no. 5, pp. 999–1006, 2014. View at: Publisher Site | Google Scholar
  105. S. Schnell, C. Wu, and S. A. Ansari, “Four-dimensional MRI flow examinations in cerebral and extracerebral vessels-ready for clinical routine?” Current Opinion in Neurology, vol. 29, no. 4, pp. 419–428, 2016. View at: Publisher Site | Google Scholar
  106. J. H. Jung, Y. Choi, and K. C. Im, “PET/MRI: technical challenges and recent advances,” Nuclear Medicine and Molecular Imaging, vol. 50, no. 1, pp. 3–12, 2016. View at: Publisher Site | Google Scholar
  107. C. Tsoumpas, D. Visvikis, and G. Loudos, “Innovations in small-animal PET/MR imaging instrumentation,” PET Clinics, vol. 11, no. 2, pp. 105–118, 2016. View at: Publisher Site | Google Scholar
  108. B. Laviña, “Brain vascular imaging techniques,” International Journal of Molecular Sciences, vol. 18, no. 1, p. 70, 2016. View at: Publisher Site | Google Scholar
  109. N. C. Institute, “Network for translational research (NTR): optical imaging in multimodality platforms,” 2016, View at: Google Scholar
  110. E. M. Sevick-Muraca, W. J. Akers, B. P. Joshi et al., “Advancing the translation of optical imaging agents for clinical imaging,” Biomedical Optics Express, vol. 4, no. 1, pp. 160–170, 2013. View at: Publisher Site | Google Scholar

Copyright © 2019 Richa Gandhi and Charalampos Tsoumpas. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.